Article Details

Urovant Sciences (UROV) Cut to “Sell” at Zacks Investment Research

Retrieved on: 2019-02-17 21:18:45

Tags for this article:

Click the tags to see associated articles and topics

Urovant Sciences (UROV) Cut to “Sell” at Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP acquired a new position in shares of Urovant Sciences in the 4th quarter valued at $72,000. Weiss Multi Strategy Advisers ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up